Mk. Robinson et al., SPECIFIC ANTIBODY-RESPONSES TO SUBTILISIN CARLSBERG (ALCALASE) IN MICE - DEVELOPMENT OF AN INTRANASAL EXPOSURE MODEL, Fundamental and applied toxicology, 34(1), 1996, pp. 15-24
An intranasal (i.n.) dosing model was developed in mice as a potential
alternative to more difficult, time-consuming, and costly guinea pig
intratracheal (GPIT) or mouse intratracheal models for assessment of t
he respiratory immunogenicity of detergent enzymes. Using a benchmark
enzyme, Alcalase (protease subtilisin Carlsberg), studies were conduct
ed to standardize the model in terms of mouse strain, dosing and serum
harvest regimen, and the primary immunoglobulin endpoint to use. The
primary assay endpoint selected was the enzyme-specific IgG1 titer det
ermined by an Alcalase-specific ELISA. This is not the primary allerge
nic antibody in mice (IgE is); however, IgG1 is coregulated with IgE v
ia the IL-4/TH2 pathway and may have a role in mediating allergic-type
responses. BDF1 mice (C57B1/6 X DBA/2) were selected as representativ
e of high responder strains, with high response associated with the H-
2(b) (C57B1/6) parent. The dosing regimen used for most studies incorp
orated three i.n. exposures (Days 1, 3, and 10) and bleeding of the an
imals on Day 15. The animals were anesthetized and then immunized by a
llowing them to inhale 5-mu l aliquots of dosing solution into each no
stril at each immunization. Positioning of the animals with their head
s down (vs up) may have allowed more of the dosing solution to remain
in the nasal region for a slightly longer period of time, but did not
change the eventual GI tract migration and excretion of each dose. The
presence of a detergent matrix in the enzyme dosing solution enhanced
the IgG1 response. Immunizing with enzyme plus detergent gave highly
consistent dose-response curves for Alcalase when evaluated over many
studies. An enzyme-specific allergic antibody (IgE) response was weak
and inconsistent under the dosing regimen used to generate the IgG1 re
sponse, but was stronger with longer-term dosing, consistent with the
delay in IgE vs IgG1 responses seen in some other studies. Using IgG1
as a surrogate for allergic sensitization, we have preliminary data sh
owing similar differential potencies between Alcalase and other test e
nzymes as detected in previous GPIT tests. On the basis of these data,
we believe the i.n. immunization/IgG1 response model is a robust tech
nique that may be useful in determining the relative immunogenicities
of detergent enzymes and other proteins. (C) 1996 Society of Toxicolog
y.